Michael Wang, MD, highlights several notable abstracts from ASH 2025 that collectively underscore continued progress in ...

Factorial Biotechnologies, a leader in next-generation single-cell sequencing solutions, and Honeycomb Biotechnologies, a pioneer in instrument-free single-cell analysis, today announced a strategic ...

According to MarketsandMarkets™, the Genomic Biomarkers Market is projected to grow from about USD 29.00 billion in 2025 to ...

Researchers at UC San Francisco have devised a method to identify pneumonia — using both genetic information and AI — that ...

According to MarketsandMarkets, the Genomic Biomarkers Market is projected to grow from about USD 29.00 billion in 2025 to USD 50.31 billion ...

Researchers find trace DNA on a Renaissance drawing linked to Leonardo da Vinci, showing how fragile artworks can preserve ...

PathAI, a global leader in AI-powered pathology, today announced a strategic collaboration with University Hospital Zurich ...

STORM Therapeutics has entered a new collaboration with US‑based AlidaBio to accelerate the development of cancer therapies that target RNA modifications.

DNA analysis of cultural artifacts shows diverse biological profiles, but contamination and mixed signals complicate historical lineage interpretation.

STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration with Alida ...

The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites ...